NO20075508L - Stable Soporphine Preparations and Administration - Google Patents

Stable Soporphine Preparations and Administration

Info

Publication number
NO20075508L
NO20075508L NO20075508A NO20075508A NO20075508L NO 20075508 L NO20075508 L NO 20075508L NO 20075508 A NO20075508 A NO 20075508A NO 20075508 A NO20075508 A NO 20075508A NO 20075508 L NO20075508 L NO 20075508L
Authority
NO
Norway
Prior art keywords
preparations
soporphine
administration
stable
pharmaceutical
Prior art date
Application number
NO20075508A
Other languages
Norwegian (no)
Inventor
Philip C Lang
George S Drummond
Original Assignee
Infacare Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/096,359 external-priority patent/US20060222668A1/en
Application filed by Infacare Pharmaceutical Corp filed Critical Infacare Pharmaceutical Corp
Publication of NO20075508L publication Critical patent/NO20075508L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmasøytiske preparater innbefattende staimsoporfin, legemiddelprodukter innbefattende farmasøytiske preparater, metoder for fremstilling av farmasøytiske preparater, og metoder for behandling av hyperbilirubinemi med legemiddelprodukter og preparater, er beskrevet.Pharmaceutical preparations including staimsoporphine, pharmaceutical products including pharmaceutical preparations, methods for the preparation of pharmaceutical preparations, and methods of treating hyperbilirubinemia with drug products and preparations are described.

NO20075508A 2005-04-01 2007-10-31 Stable Soporphine Preparations and Administration NO20075508L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/096,359 US20060222668A1 (en) 2005-04-01 2005-04-01 Stannsoporfin compositions, drug products and methods of manufacture
US11/239,769 US20060222669A1 (en) 2005-04-01 2005-09-30 Stannsoporfin compositions and administration
PCT/US2006/012185 WO2006107806A2 (en) 2005-04-01 2006-03-31 Stannsoporfin compositions and administration

Publications (1)

Publication Number Publication Date
NO20075508L true NO20075508L (en) 2007-10-31

Family

ID=37073987

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075508A NO20075508L (en) 2005-04-01 2007-10-31 Stable Soporphine Preparations and Administration

Country Status (6)

Country Link
EP (1) EP1865777A4 (en)
KR (1) KR20080004531A (en)
AU (1) AU2006232330A1 (en)
CA (1) CA2602794A1 (en)
NO (1) NO20075508L (en)
WO (1) WO2006107806A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375216B2 (en) 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
ES2556359T3 (en) 2006-10-04 2016-01-15 Infacare Pharmaceutical Corporation Procedure for large-scale production of high purity stansoporphine
EP2691398B1 (en) 2011-03-30 2016-09-28 InfaCare Pharmaceutical Corporation Methods for synthesizing metal mesoporphyrins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692440A (en) * 1985-03-25 1987-09-08 The Rockefeller University Therapeutic use of tin mesoporphyrin
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
US7375216B2 (en) * 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation

Also Published As

Publication number Publication date
EP1865777A4 (en) 2008-07-16
WO2006107806A2 (en) 2006-10-12
KR20080004531A (en) 2008-01-09
WO2006107806A3 (en) 2007-07-12
AU2006232330A1 (en) 2006-10-12
CA2602794A1 (en) 2006-10-12
EP1865777A2 (en) 2007-12-19

Similar Documents

Publication Publication Date Title
NO20055173L (en) Pharmaceutical combination combination comprising modafinil and another drug
BRPI0413427A (en) active pyridylpyrrole derivatives as kinase inhibitors
CY1117667T1 (en) 3,4-DYRYLYZRAZOLA AS PROTEIN MODEL INSPECTORS
DK1636236T3 (en) Pyrazolo-quinazoline derivatives, a process for their preparation, and their use as kinase inhibitors
NO20070782L (en) Tetrapeptidanaloger.
HK1136292A1 (en) Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
MXPA06000302A (en) Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
NO20075136L (en) New liposome preparations
NO20090305L (en) Cyclosporine formulations
ATE514699T1 (en) SUBSTITUTED PYRROLOPYRAZOLE DERIVATIVES AS KINASE INHIBITORS
NO20062504L (en) Compositions and dosage forms for improved absorption
WO2009071480A3 (en) Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
BRPI0413438A (en) active pyrimidylpyrrole derivatives as kinase inhibitors
ATE477805T1 (en) 9A-CARBAMOYL-Y-AMINOPROPYL AND 9A-THIOCARBAMOYL-Y-AMINOPROPYL AZALIDES WITH ANTIMALARIA ACTIVITY
UA97629C2 (en) Pharmaceutical formulation exhibiting antitumor activity and methods
UA102219C2 (en) Substotuted pyrazolo-quinazoline derivatives, process for the preparation and use thereof as kinase inhibitors
EP1503748A4 (en) Drugs for mitigating taxane-induced neurotoxicity
NO20076120L (en) Stable nanoparticle formulations
NO20075508L (en) Stable Soporphine Preparations and Administration
UA92604C2 (en) Stannsoporfin composition having a physiological osmolarity and use thereof
SE0300457D0 (en) Novel compounds
DE50304524D1 (en) DRUGS INCLUDED SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLE
TW200500073A (en) Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof
NO20060045L (en) Indole derivatives with apoptosis-inducing effect
CY1115559T1 (en) AMYLOIDES-BETA PETIDIUM ANTIBODIES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application